References
Arneric S. P., Sullivan J. P., and Williams M. (1995) Neuronal nicotinic acetylcholine receptors—novel targets or CNS therapeutics, in Psychopharmacology: The Fourth Generation of Progress, Bloom F. E., and Kupfer D. J., eds. Raven Press, NY, pp. 1–16.
Bencherif M., Bane A. J., Miller C. H., Dull G. M., and Gatto G. J. (2000) TC-2559: a novel orally active ligand selective at neuronal acetylcholine receptors. Eur. J. Pharmacol. 409, 45–55.
Bontempi B., Whelan K. T., Risbrough V. B., Rao T. S., Buccafusco J. J., Lloyd G.K., and Menzaghi F. (2001) SIB-1553A, (+/−)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl] thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J. Pharmacol. Exp. Ther. 299, 297–306.
Lippiello P. M., Bencherif M., Gray J. A., Peters S., Grigoryan G., Hodges H., and Collins A. C. (1996) TC-2403: a nicotinic agonist with CNS selectivity. I. In vivo characterization. J. Pharmacol. Exp. Ther. 279, 1422–1429.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lippiello, P., Letchworth, S.R., Gatto, G.J. et al. Ispronicline. J Mol Neurosci 30, 19–20 (2006). https://doi.org/10.1385/JMN:30:1:19
Issue Date:
DOI: https://doi.org/10.1385/JMN:30:1:19